MedTrace Logo

Growth and Safety Clinical Trial on a New Infant Formula.

NCT04671576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2022-09-28

No results posted yet for this study

Summary

The aim of the study is to assess age-appropriate growth of healthy infants fed a new organic milk-based infant formula.

Conditions

  • Healthy Growth

Interventions

OTHER

Control Infant Formula

Powder, standard commercial infant formula.

OTHER

Organic Infant Formula

Powder, organic milk-based infant formula.

Sponsors & Collaborators

  • Paidion Research, Inc.

    collaborator INDUSTRY

  • Nara Organics

    lead INDUSTRY

Principal Investigators

  • Amanda Fingarson, DO · Paidion Research, Inc.

  • Tiffany Petty, MD · Telehub Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-12
Primary Completion
2022-08-12
Completion
2022-08-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671576 on ClinicalTrials.gov